SCHEMBL5589179

SCHEMBL5589179

Cc1ccccc1/N=C/c1cccc(/C=N/c2ccccc2C)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.51
MAPT P10636 5/20 0.51
KDM4E B2RXH2 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
MPI P34949 1/20 0.51
RECQL P46063 1/20 0.51
CYP2C9 P11712 2/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
PKM P14618 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
LMNA P02545 4/20 0.40
HPGD P15428 4/20 0.40
HTT P42858 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HSD17B10 Q99714 1/20 0.37
NR4A1 P22736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589183 1.00 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL5590195 0.98 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EL3MBTL1POLB
Hydrochloric Acid SCHEMBL15949866 0.96 ALDH1A1 (0.49) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL6142136 0.82 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL16471869 0.81 NR4A1 (0.59) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL5589937 0.80 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL5589935 0.80 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL5589346 0.80 CTH (0.36) ALDH1A1MAPTKDM4ECYP2C9NPC1
SCHEMBL5589354 0.80 CTH (0.36) ALDH1A1MAPTKDM4ECYP2C9NPC1
SCHEMBL5587144 0.79 ALDH1A1 (0.54) ALDH1A1MAPTKDM4EL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562799-B1 ETHYLENE OLIGOMERIZATION PROCESSES CHEVRON PHILLIPS CHEMICAL CO LP (US) 2023-08-23 EP claimed
US-11358914-B2 Ethylene oligomerization processes CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2022-06-14 US claimed
US-20210214289-A1 Ethylene Oligomerization Processes CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-07-15 US claimed
US-10793489-B2 Ethylene oligomerization processes CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2020-10-06 US claimed
US-10604457-B2 Ethylene oligomerization processes CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2020-03-31 US claimed
US-20200095178-A1 Ethylene Oligomerization Processes CHEVRON PHILLIPS CHEMICAL COMPANY LP 2020-03-26 US claimed
EP-3562798-A1 ETHYLENE OLIGOMERIZATION PROCESSES Chevron Phillips Chemical Company LP (US) 2019-11-06 EP claimed
EP-3562799-A1 ETHYLENE OLIGOMERIZATION PROCESSES Chevron Phillips Chemical Company LP (US) 2019-11-06 EP claimed
EP-3562800-A1 ETHYLENE OLIGOMERIZATION PROCESSES Chevron Phillips Chemical Company LP (US) 2019-11-06 EP claimed
US-20190276377-A1 Ethylene Oligomerization Processes CHEVRON PHILLIPS CHEMICAL COMPANY LP 2019-09-12 US claimed
US-10407360-B2 Ethylene oligomerization processes CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-09-10 US claimed
US-20190194089-A1 Ethylene Oligomerization Processes CHEVRON PHILLIPS CHEMICAL COMPANY LP 2019-06-27 US claimed
WO-2018128861-A1 ETHYLENE OLIGOMERIZATION PROCESSES CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-07-12 WO claimed
WO-2018125824-A1 ETHYLENE OLIGOMERIZATION PROCESSES CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-07-05 WO claimed
US-20180186709-A1 Ethylene Oligomerizaton Processes CHEVRON PHILLIPS CHEMICAL COMPANY LP 2018-07-05 US claimed
WO-2018125826-A1 ETHYLENE OLIGOMERIZATION PROCESSES CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-07-05 WO claimed
US-20180186708-A1 Ethylene Oligomerization Processes CHEVRON PHILLIPS CHEMICAL COMPANY LP 2018-07-05 US claimed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP claimed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180186708-A1 Ethylene Oligomerization Processes MAX, AP1M1, AP2M1 ALDH1A1 4669/4885MAPT 922/4885KDM4E 2674/4885
US-20190276377-A1 Ethylene Oligomerization Processes NOD2, AP1M1, AP2M1 ALDH1A1 4471/4885MAPT 2760/4885KDM4E 3977/4885
US-20190194089-A1 Ethylene Oligomerization Processes NOD2, AP1M1, AP2M1 ALDH1A1 4471/4885MAPT 2760/4885KDM4E 3977/4885
US-10793489-B2 Ethylene oligomerization processes NOD2, AP1M1, AP2M1 ALDH1A1 4471/4885MAPT 2760/4885KDM4E 3977/4885
US-10604457-B2 Ethylene oligomerization processes EPS15, PICALM, AP2M1 ALDH1A1 4824/4885MAPT 1342/4885KDM4E 3129/4885
US-10407360-B2 Ethylene oligomerization processes NOD2, AP1M1, AP2M1 ALDH1A1 4471/4885MAPT 2760/4885KDM4E 3977/4885
US-20200095178-A1 Ethylene Oligomerization Processes NOD2, AP1M1, AP2M1 ALDH1A1 4471/4885MAPT 2760/4885KDM4E 3977/4885
US-20180186709-A1 Ethylene Oligomerizaton Processes PICALM, EPS15, EPN1 ALDH1A1 4825/4885MAPT 1506/4885KDM4E 3394/4885
US-20210214289-A1 Ethylene Oligomerization Processes MAX, AP1M1, AP2M1 ALDH1A1 4669/4885MAPT 922/4885KDM4E 2674/4885
US-11358914-B2 Ethylene oligomerization processes MAX, AP1M1, AP2M1 ALDH1A1 4669/4885MAPT 922/4885KDM4E 2674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.